Basic Information
Nucs AI Develops AI-Driven Healthcare Platform for Prostate Cancer Analysis and Evidence-Based Clinical ManagementNucs AI develops an artificial intelligence (AI)-driven healthcare platform designed to analyze prostate cancer changes and provide evidence-based decisions for clinical management. The company's products offer functions such as automatic tumor detection, quantification, and radiopharmaceutical treatment outcome prediction by analyzing scans, enabling clinicians to make informed treatment decisions and potentially avoid unnecessary surgeries for certain patients.
Nucs AI Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2024
--
info@nucs.ai

